Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The induction of immune tolerance to specific allergens is a process by which the immune system becomes unresponsive or less reactive to substances that would otherwise trigger allergic responses. This is achieved through controlled exposure to allergens, leading to a shift in immune response and the development of regulatory mechanisms that suppress allergy-associated inflammation. Key mechanisms include the induction of regulatory T cells (Tregs), cytokine modulation (increased IL-10 and TGF-β, decreased IL-4), antibody profile shifts (increase in allergen-specific IgG4 and IgA, decrease in IgE), and altered dendritic cell phenotype. Allergen-specific immunotherapy leverages these mechanisms to reduce or eliminate clinical symptoms upon subsequent exposures.
Expansion/functional enhancement of allergen-specific regulatory lymphocytes, shift from Th2 to Th1/Treg profile, induction of blocking antibodies (IgG4), suppression of effector cell function (mast cells, eosinophils).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Induction of Tolerance via Exposure to Specific Allergens).